Table 2

Response to treatment

		SOF LED	SOF DACLA	P value
		N=51	N=77	P value
Response	SVR	50 (98.03%)	74 (96.1%)	0.275
Response	Relapse	1 (1.97%)	3 (3.9%)	0.275
Treatment	Completed	50 (98%)	76 (98.7%)	1
Treatment	Stopped in the last month due to marked hyperuricaemia	1 (2%)	1 (1.3%)	1

Fisher exact test (more than 20% of cells have expected count <5) for qualitative data between the two groups.
Significant level at p value <0.05.
DACLA, daclatsvir; LED, ledipasvir; SOF, sofosbuvir; SVR, sustained virological response.